Trials / Unknown
UnknownNCT01091324
Dextromethorphan and Silymarin in Chronic Kidney Disease (CKD) Patients
The Reno-protective and Cardiovascular Effect of Dextromethorphan and Silymarin in Patients With Chronic Kidney Disease
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 45 (estimated)
- Sponsor
- National Cheng-Kung University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The investigators test the renal and cardiovascular protective effects dextromethorphan and silymarin on patients with the proteinuric chronic kidney diseases, who enrolled in our clinical trial, had progressing kidney diseases and merit aggressive anti-inflammatory therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dextromethorphan | 60 mg, bid |
| DRUG | Silymarin | 150 mg , tid |
| DRUG | sugar pill | placebo |
Timeline
- Start date
- 2010-01-01
- Primary completion
- 2010-06-01
- Completion
- 2010-07-01
- First posted
- 2010-03-24
- Last updated
- 2010-03-24
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT01091324. Inclusion in this directory is not an endorsement.